Humana
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Track Humana in real time with a live news feed covering Humana stock news, official press releases, company announcements, and an archive of historical Humana news. ...more
Loading news...
Loading more...
5:32 PM | Friday | May 15, 2026
Sign in to download news snippet
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Humana Inc. (“Humana” or “the Company”) (NYSE: HUM).
On January 18, 2024, the Company announced its financial results for the fourth quarter and full year 2023, disclosing that its benefits expense ratio increased to approximately 91.4% for the fourth quarter of 2023 and approximately.
No data available for this time period.
Change the time range to see results.
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Humana Inc. (“Humana” or “the Company”) (NYSE: HUM).
On January 18, 2024, the Company announced its financial results for the fourth quarter and full year 2023, disclosing that its benefits expense ratio increased to approximately 91.4% for the fourth quarter of 2023 and approximately.
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Humana Inc. (“Humana” or “the Company”) (NYSE: HUM).
On January 18, 2024, the Company announced its financial results for the fourth quarter and full year 2023, disclosing that its benefits expense ratio increased to approximately 91.4% for the fourth quarter of 2023 and approximately.
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana invests more than $1 million to advance health outcomes across Louisiana through grants that support statewide priorities.
Read full article
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended March 31, 2026 (1Q26) versus the quarter ended March 31, 2025 (1Q25) as noted in the tables below. Consolidated income before income taxes and equity in net losses (pretax results) in millions 1Q26 (a) 1Q25 (a) Generally Accepted Accounting Principles (GAAP) $1,595 $1,691 Amortization associated with identifiable intangibles 11 15 Pu.
Read full article
LOUISVILLE, Ky. & DALLAS--(BUSINESS WIRE)--CenterWell Pharmacy®, a leader in specialty pharmacy and home delivery pharmacy and part of Humana Inc. (NYSE:HUM), today announced a deepened partnership with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) to develop new, end-to-end employer prescription solutions. As part of this collaboration, Cost Plus Drugs has selected CenterWell Pharmacy® as a pharmacy partner. In addition, Cost Plus Drugs' digital pharmacy SaaS solution, SwiftyRx™, will be.
PHILADELPHIA, April 21, 2026 (GLOBE NEWSWIRE) -- Kaskela Law is investigating potential breach of fiduciary duty claims concerning Humana Inc. (NYSE: HUM) (“Humana”) on behalf of the company's long-term shareholders. Click here for additional information about your shareholder legal rights: https://kaskelalaw.com/case/humana/ Recently a federal securities fraud complaint was filed against Humana on behalf of certain investors who purchased shares of the company's stock between July 27, 2022 and October 1, 2024 (the “Wrongdoing Period”).
Read full article
LOUISVILLE, Ky.--(BUSINESS WIRE)--CenterWell Introduces the Fulfillment Index, a New Measure of What It Means to Age Well.
Read full article
LOUISVILLE, Ky., April 19, 2026 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from the Humana, Inc. data breach.
Read full article
LOUISVILLE, Ky.--(BUSINESS WIRE)--A new study published in the Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation shows how an innovative phone-based inhaler education program helped Medicare Advantage beneficiaries with COPD use their inhalers more effectively. Researchers from Humana Healthcare Research and University of Chicago Medicine (UChicago Medicine) found that Humana members with COPD and low medication adherence who participated in the program in 2020 significantl.
Read full article
Program launching June 1, 2026 will expand access to community-based palliative care for members living with serious illness HOUSTON, April 14, 2026 /PRNewswire/ -- Tuesday Health today announced a new partnership with Humana Inc. (NYSE: HUM) to expand access to value-based palliative care for Texans living with serious illness, marking another step in the company's growing national footprint. Launching June 1, the program will support eligible Humana members and their caregivers with coordinated clinical guidance, proactive symptom management and ongoing support designed to improve quality of life and help members receive care aligned with their individual goals.
Read full article
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Robert S. Field has been elected as a member of the Company's Board of Directors, effective immediately following the Company's 2026 Annual Meeting of Stockholders. Field is the Principal and Managing Member of ηMed Capital Management LLC, an investment firm focused on U.
S. healthcare services companies, primarily in the managed care industry. He previously served as a senior analyst at Luxor Capital, a multi-strateg.
No data available for this time period.
Change the time range to see results.